tiprankstipranks
Sanofi (DE:SNW)
XETRA:SNW
Germany Market
SNW
Sanofi
RESEARCH TOOLSreports

Sanofi (SNW) Stock News & Sentiment

31 Followers
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Premium
Company Announcements
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
16d ago
SNYNF
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
Premium
Company Announcements
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
18d ago
SNYNF
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
Premium
Company Announcements
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
1M ago
REGN
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
Premium
Company Announcements
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
2M ago
REGN
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
Premium
Ratings
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
2M ago
SNY
Is SNYNF a Buy, Before Earnings?
Premium
Pre-Earnings
Is SNYNF a Buy, Before Earnings?
2M ago
Sanofi Completes Key Amlitelimab Vaccine-Response Study in Atopic Dermatitis
Premium
Company Announcements
Sanofi Completes Key Amlitelimab Vaccine-Response Study in Atopic Dermatitis
2M ago
SNYNF
More DE:SNW News >

SNW News on the Web

White House says imposing tariffs on patented pharmaceutical products
TipRanks News
Neutral
Trump Trade: President says Iran war will still take weeks
TipRanks News
Neutral
Trump administration readying new pharmaceutical tariffs, FT reports
TipRanks News
Neutral
Sanofi (SNYNF) Gets a Hold from Kepler Capital
TipRanks News
Neutral
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
TipRanks News
Neutral
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
TipRanks News
Neutral
Sanofi: European Commission Grants Conditional Marketing Authorisation For Rezurock
rttnews
Bullish
Is There Now An Opportunity In Sanofi (ENXTPA:SAN) After Recent Share Price Weakness
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
DE:SNW
Sector Average
Media Buzz
This Week11 articles
Weekly Average10.75 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SNW’s Media Buzz Sentiment?
11 articles about DE:SNW were published this week. In an average week, 10.75 articles are published.
    What is DE:SNW’s weekly average amount of articles?
    In an average week, 10.75 articles about DE:SNW are published.
      What is DE:SNW’s News Sentiment?
      100% of articles about DE:SNW were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        2273Gushengtang Holdings Limited
        LTRNLantern Pharma
        CNTBConnect Biopharma Holdings
        Showing the stocks with the most bullish news sentiment over the past week